Irritable Bowel Syndrome
📧 Sign up to get email alerts when something new happens for Irritable Bowel Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-03-16Clinical Trial Update: Frequency of Sleep Abnormalities in Patients With Irritable Bowel Syndrome and Effect of Pharmacological Intervention [Phase 3]
Phase 3 clinical trial update investigating the frequency of sleep abnormalities in patients with Irritable Bowel Syndrome and the effect of…
-
CLINICAL_TRIALS trial_result · 2020-03-13Clinical Trial Update: Evaluation of the Efficacy of Two Probiotic Strains for Irritable Bowel Syndrome [Phase 2]
Phase 2 trial evaluating the efficacy of two probiotic strains for Irritable Bowel Syndrome has completed.
-
CLINICAL_TRIALS trial_result · 2020-01-23Clinical Trial Update: Combination of Alverine-simeticone and i3.1 Probiotic in IBS-D and IBS-M in Mexico [Phase 4]
Phase 4 clinical trial update evaluating a combination of alverine-simeticone and i3.1 probiotic for irritable bowel syndrome (IBS) in Mexic…
-
CLINICAL_TRIALS trial_result · 2020-01-03Clinical Trial Update: Ethosuximide and Pentoxifylline in the Treatment of Abdominal Pain Related to Irritable Bowel Syndrome [Phase 3]
Phase 3 clinical trial evaluating ethoxysuximide and pentoxifylline for abdominal pain in irritable bowel syndrome is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2019-12-27Clinical Trial Update: Evaluation of the Efficacy and Safety of Lubiprostone in Adults With Mixed or Unsubtyped Irritable Bowel Syndrome [Phase 2]
Phase 2 trial evaluating lubiprostone for adults with mixed or unsubtyped irritable bowel syndrome was terminated with results posted in 201…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-11-25Clinical Trial Update: A Study of Crofelemer to Treat Diarrhea Irritable Bowel Syndrome [Phase 2]
Phase 2 clinical trial of crofelemer for diarrhea-predominant irritable bowel syndrome has completed.
-
CLINICAL_TRIALS trial_result · 2019-11-25Clinical Trial Update: Study to Assess the Efficacy and Safety of Rifaximin Administered BID in the Treatment of Patients With Diarrhea-Associated Irritable Bowel Syndrome [Phase 2]
Phase 2 trial update assessing the efficacy and safety of rifaximin dosed twice daily for diarrhea-associated irritable bowel syndrome has c…
-
CLINICAL_TRIALS trial_result · 2019-11-25Clinical Trial Update: Diarrhea Predominant Irritable Bowel Syndrome in Females [Phase 2]
Phase 2 clinical trial update for diarrhea-predominant irritable bowel syndrome in females.
-
CLINICAL_TRIALS trial_result · 2019-10-22Clinical Trial Update: Efficacy, Safety, and Tolerability of JNJ-27018966 (Eluxadoline) in the Treatment of Irritable Bowel Syndrome With Diarrhea [Phase 2]
Phase 2 trial assessing eluxadoline (JNJ-27018966) for irritable bowel syndrome with diarrhea; results completed and posted in 2019, focusin…
-
CLINICAL_TRIALS trial_result · 2019-08-21Clinical Trial Update: Biomarkers for Intestinal Permeability in Patients With Constipation
Clinical trial update studying biomarkers for intestinal permeability in patients with constipation; completed with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-08-09Clinical Trial Update: A Phase 1, First Time in Human (FTIH) Study to Evaluate GSK3352589, a REarranged During Transfection (RET) Growth Factor Receptor Tyrosine Kinase Inhibitor, in Healthy Volunteers [Phase 1]
Phase 1 first-in-human study of GSK3352589 (a RET tyrosine kinase inhibitor) in healthy volunteers; completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-07-02Clinical Trial Update: Fecal Microbiota Transplantation for the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome [Phase 2]
Phase 2 clinical trial evaluating fecal microbiota transplantation for diarrhea-predominant irritable bowel syndrome has completed with resu…
-
CLINICAL_TRIALS trial_result · 2019-06-14Clinical Trial Update: The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C) [Phase 3]
Phase 3 trial update for plecanatide in irritable bowel syndrome with constipation (IBS-C) completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-02-22Clinical Trial Update: Ileocecal Sphincter Reflex by Cecal Distension During Colonoscopy
The clinical trial 'Ileocecal Sphincter Reflex by Cecal Distension During Colonoscopy' sponsored by Northwell Health for Irritable Bowel Syn…
-
CLINICAL_TRIALS trial_result · 2019-02-21Clinical Trial Update: Microbiota Profiling in IBS
The clinical trial investigating microbiota profiling in irritable bowel syndrome has completed. The sponsor is Wageningen University.
-
CLINICAL_TRIALS trial_result · 2019-02-18Clinical Trial Update: Safety and Tolerability of Serum Derived Bovine Immunoglobulin in Children With Diarrhea Predominant IBS [NA]
This trial update reports on the safety and tolerability of serum-derived bovine immunoglobulin in pediatric patients with diarrhea-predomin…
-
CLINICAL_TRIALS trial_result · 2019-01-31Clinical Trial Update: Assessing Associations Between IBS Symptoms, Nutrition and QoL in IBS Patients Using a Questionnaire
A completed Wageningen University study evaluated associations between irritable bowel syndrome symptoms, nutrition, and quality of life in …
-
CLINICAL_TRIALS trial_result · 2019-01-24Clinical Trial Update: A Novel Formulation of Bifidobacterium Longum BB536 and Lactobacillus Rhamnosus HN001 With Vitamin B6 on IBS Patients [Phase 3]
A Phase 3 trial evaluating a novel probiotic formulation consisting of Bifidobacterium longum BB536, Lactobacillus rhamnosus HN001, and Vita…
-
CLINICAL_TRIALS trial_result · 2019-01-23Clinical Trial Update: Irritable Bowel Syndrome Evaluation and Treatment in Primary Care [Phase 4]
A Phase 4 clinical trial evaluating the evaluation and treatment of Irritable Bowel Syndrome in primary care has completed.
-
CLINICAL_TRIALS trial_result · 2019-01-18Clinical Trial Update: BÜHLMANN fCAL™ ELISA - Aid in Differentiation of IBD From IBS
A completed clinical trial evaluates the Bühlmann fCAL ELISA as a diagnostic aid to differentiate inflammatory bowel disease from irritable …
-
CLINICAL_TRIALS trial_result · 2018-11-07Clinical Trial Update: Spinal Cord Stimulation for Pain Relief in Irritable Bowel Syndrome [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial evaluating spinal cord stimulation for pain relief in irritable bowel syndrome. The study includes IBS …
-
CLINICAL_TRIALS trial_result · 2018-11-02Clinical Trial Update: Peppermint Oil for the Treatment of Irritable Bowel Syndrome: Optimizing Therapeutic Strategies Using Targeted Delivery [Phase 3]
A Phase 3 trial evaluating targeted delivery of peppermint oil for irritable bowel syndrome with abdominal pain has completed, exploring opt…
-
CLINICAL_TRIALS trial_result · 2018-10-29Clinical Trial Update: Efficacy/Safety Study to Confirm Iberogast's Efficacy in Patients With Irritable Bowel Syndrome Diagnosed on ROME III Criteria Compared to Placebo [Phase 3]
Phase 3 clinical trial assessing Iberogast for efficacy and safety in irritable bowel syndrome compared with placebo has completed.
-
CLINICAL_TRIALS trial_result · 2018-09-04Clinical Trial Update: Efficacy, Safety, and Tolerability of Eluxadoline in the Treatment of Participants With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-d) [Phase 3]
Phase 3 trial update for eluxadoline in diarrhea-predominant IBS assessing efficacy, safety, and tolerability; completed with results posted…
-
CLINICAL_TRIALS trial_result · 2018-08-08Clinical Trial Update: Transplantation of Anaerobic Cultured Human Intestinal Microbiota in Irritable Bowel Syndrome [Phase 2]
Phase 2 trial update on transplantation of anaerobic cultured human intestinal microbiota for irritable bowel syndrome (IBS).